Elevance Health
1,661 hedge funds and large institutions have $98.5B invested in Elevance Health in 2023 Q4 according to their latest regulatory filings, with 242 funds opening new positions, 596 increasing their positions, 595 reducing their positions, and 86 closing their positions.
181% more first-time investments, than exits
New positions opened: 242 | Existing positions closed: 86
14% more capital inflows, than outflows
Capital inflows: $5.05B | Capital outflows: $4.43B
10% more call options, than puts
Call options by funds: $821M | Put options by funds: $744M
9% more funds holding
Funds holding: 1,528 → 1,661 (+133)
0.69% more ownership
Funds ownership: 88.19% → 88.88% (+0.69%)
0% more repeat investments, than reductions
Existing positions increased: 596 | Existing positions reduced: 595
11% less funds holding in top 10
Funds holding in top 10: 55 → 49 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$458M |
| 2 |
Neuberger Berman Group
New York
|
+$438M |
| 3 |
Man Group
London,
United Kingdom
|
+$292M |
| 4 |
BlackRock
New York
|
+$248M |
| 5 |
Morningstar Investment Services
Chicago,
Illinois
|
+$236M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Putnam Investments
Boston,
Massachusetts
|
-$387M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$316M |
| 3 |
Two Sigma Advisers
New York
|
-$230M |
| 4 |
Farallon Capital Management
San Francisco,
California
|
-$166M |
| 5 |
Two Sigma Investments
New York
|
-$164M |
ELV Hedge Fund Activity: Q4 2023 in Review
1,661 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2023, worth a combined $98.5B — up 8.3% from $90.9B a quarter earlier.
Buyers outnumbered sellers: 242 funds opened new ELV positions and 86 closed out — a net gain of 156 holders — while 596 added to existing stakes and 595 trimmed.
The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $458M. The largest seller was Putnam Investments, cutting an estimated $387M.
- 1,661 institutional investors held Elevance Health (ELV) as of Q4 2023, up from 1,528 in Q3 2023.
- Funds reported $98.5B of Elevance Health stock for Q4 2023, up 8.3% quarter-over-quarter.
- 242 funds opened new Elevance Health positions in Q4 2023 and 86 closed out, a net change of +156 holders.
- The largest Elevance Health buyer in Q4 2023 was Massachusetts Financial Services, an estimated $458M added.
- The largest Elevance Health seller in Q4 2023 was Putnam Investments, an estimated $387M sold.
Based on aggregated 13F filings for Q4 2023.